Blocking Junctional Adhesion Molecule C Enhances Dendritic Cell Migration and Boosts the Immune Responses against Leishmania major

PLoS Pathogens

Volumn 10, Issue 12, 2014, Pages

  Ballet, Romain ^a   Emre, Yalin ^a   Jemelin, Stéphane ^a   Charmoy, Mélanie ^b   Tacchini Cottier, Fabienne ^b   Imhof, Beat A ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE C; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; IMMUNOGLOBULIN; JAM3 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DIAPEDESIS; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIESIS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; INNATE IMMUNITY; LEISHMANIA; MOUSE; NONHUMAN; PARASITE LOAD; RECEPTOR DOWN REGULATION; SKIN DEFECT; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; LEISHMANIA MAJOR; PARASITOLOGY; PATHOLOGY; SKIN; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

LEISHMANIA MAJOR; MUS;

ANIMALS; CELL ADHESION MOLECULES; DENDRITIC CELLS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOGLOBULINS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; SKIN; TH1 CELLS; TH2 CELLS;

EID: 84919681163     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004550     Document Type: Article

References (48)

1. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. The Lancet 366: 1561–1577.
2. Kaye P, Scott P, (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604–615.
3. Sacks D, Noben-Trauth N, (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845–858.
4. Heinzel F, Sadick M, Mutha S, Locksley R, (1991) Production of interferon-gamma, interleukin-2, interleukin-4, and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. PNAS 88: 7011–7015.
5. Wang ZE, Reiner LR, Zheng S, Dalton DK, Lockley RM, (1994) CD4 + Effector Cells Default to the Th2 Pathway in Interferon y-deficient Mice Infected with Leishmania major. J Exp Med 179: 1367–1371.
6. Liew F, Millott S, Parkinson C, Palmer R, Moncada S, (1990) Macrophages killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 144: 4794–4797.
7. Tacchini-Cottier F, Weinkopff T, Launois P, (2012) Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model. Front Immunol 3: 32.
8. Ng LG, Hsu A, Mandell MA, Roediger B, Hoeller C, et al. (2008) Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog 4: e1000222.
9. Von Stebut E, Belkaid Y, Jakob T, Sacks D, Udey M, (1998) Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity. J Exp Med 188: 1547–1552.
10. Leon B, Lopez-Bravo M, Ardavin C, (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519–531.
11. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog 5: e1000494.
12. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, et al. (2000) CC Chemokine Receptor (CCR)2 Is Required for Langerhans Cell Migration and Localization of T Helper Cell Type 1 (Th1)-inducing Dendritic Cells: Absence of CCR2 Shifts the Leishmania major–resistant Phenotype to a Susceptible State Dominated by Th2 Cytokines, B Cell Outgrowth, and Sustained Neutrophilic Inflammation. J Exp Med 192: 205–218.
13. Ley K, Laudanna C, Cybulsky MI, Nourshargh S, (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678–689.
14. Scheiermann C, Colom B, Meda P, Patel NS, Voisin MB, et al. (2009) Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. Arterioscler Thromb Vasc Biol 29: 1509–1515.
15. Liang T, Chiu H, Gurney A, Sidle A, Tumas D, et al. (2002) Vascular Endothelial-Junctional Adhesion Molecule (VE-JAM)/JAM 2 Interacts with T, NK, and Dendritic Cells Through JAM 3. J Immunol 168: 1618–1626.
16. Santoso S, Sachs UJH, Kroll H, Linder M, Ruf A, et al. (2002) The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1. J Exp Med 196: 679–691.
17. Zen K, Babbin BA, Liu Y, Whelan JB, Nusrat A, et al. (2004) JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell 15: 3926–3937.
18. Morris AP, Tawil A, Berkova Z, Wible L, Smith CW, et al. (2006) Junctional Adhesion Molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions. Cell Commun Adhes 13: 233–247.
19. Scheiermann C, Meda P, Aurrand-Lions M, Madani R, Yiangou Y, et al. (2007) Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. Science 318: 1472–1475.
20. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, et al. (2005) Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell 16: 4992–5003.
21. Cunningham SA, Rodriguez JM, Arrate MP, Tran TM, Brock TA, (2002) JAM2 interacts with alpha4beta1. Facilitation by JAM3. J Biol Chem 277: 27589–27592.
22. Aurrand-Lions M, Duncan L, Ballestrem C, Imhof BA, (2001) JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem 276: 2733–2741.
23. Bradfield PF, Scheiermann C, Nourshargh S, Ody C, Luscinskas FW, et al. (2007) JAM-C regulates unidirectional monocyte transendothelial migration in inflammation. Blood 110: 2545–2555.
24. Woodfin A, Voisin MB, Beyrau M, Colom B, Caille D, et al. (2011) The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 12: 761–769.
25. Vestweber D, (2012) Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Ann N Y Acad Sci 1257: 184–192.
26. Charmoy M, Brunner-Agten S, Aebischer D, Auderset F, Launois P, et al. (2010) Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog 6: e1000755.
27. Ribeiro-Gomes FL, Peters NC, Debrabant A, Sacks DL, (2012) Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response. PLoS Pathog 8: e1002536.
28. Miles AA, Miles EM, (1952) Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118: 228–257.
29. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, et al. (2000) The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3b, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes. Cell 103: 757–768.
30. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, Imhof B, (2001) Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98: 3699–3707.
31. Lamagna C, Hodivala-Dilke KM, Imhof BA, Aurrand-Lions M, (2005) Antibody against Junctional Adhesion Molecule-C Inhibits Angiogenesis and Tumor Growth. Cancer Res 65: 5703–5710.
32. Li X, Stankovic M, Lee BP, Aurrand-Lions M, Hahn CN, et al. (2009) JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins. Arterioscler Thromb Vasc Biol 29: 1200–1206.
33. Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, et al. (2010) Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma. Glia 58: 524–537.
34. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T, (2006) Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 203: 2703–2714.
35. Spindler V, Schlegel N, Waschke J, (2010) Role of GTPases in control of microvascular permeability. Cardiovasc Res 87: 243–253.
36. Goddard LM, Iruela-Arispe ML, (2013) Cellular and molecular regulation of vascular permeability. Thromb Haemost 109: 407–415.
37. Wessel F, Winderlich M, Holm M, Frye M, Rivera-Galdos R, et al. (2014) Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol
38. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, et al. (2008) In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies. Science 321: 970–974.
39. Tacchini-Cottier F, Zweifel C, Belkaid Y, Mukankundiye C, Vasei M, et al. (2000) An Immunomodulatory Function for Neutrophils During the Induction of a CD4 + Th2 Response in BALB/c Mice Infected with Leishmania major. J Immunol 165: 2628–2636.
40. Lima GM, Vallochi AL, Silva UR, Bevilacqua EM, Kiffer MM, et al. (1998) The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis. Immunol Lett 64: 145–151.
41. Ribeiro-Gomes FL, Otero AC, Gomes NA, Moniz-de-Souza MCA, Finkelstein LC, et al. (2004) Macrophage Interactions with Neutrophils Regulate Leishmania major Infection. J Immunol 172: 4454–4462.
42. Chen L, Zhang ZH, Watanabe T, Yamashita T, Kobayakawa T, et al. (2005) The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice. Parasitol Int 54: 109–118.
43. Serbina NV, Pamer EG, (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7: 311–317.
44. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, et al. (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204: 2349–2362.
45. Pflicke H, Sixt M, (2009) Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med 206: 2925–2935.
46. Zimmerli C, Lee BP, Palmer G, Gabay C, Adams RH, et al. (2009) Adaptive Immune Response in JAM-C-Deficient Mice: Normal Initiation but Reduced IgG Memory. J Immunol 182: 4728–4736.
47. Zaph C, Scott P, (2003) Th1 Cell-Mediated Resistance to Cutaneous Infection with Leishmania major Is Independent of P- and E-Selectins. The Journal of Immunology 171: 4726–4732.
48. Kropf P, Kadolsky UD, Rogers M, Cloke TE, Müller I, (2010) The Leishmaniasis Model. Methods in Microbiology 37: 307–328.